Skip to main content
. 2022 Aug 2;19(15):9465. doi: 10.3390/ijerph19159465

Table 4.

Summary of subgroup analyses.

Screening Type Sub-Group Studies Included
(References)
Pooled Estimate
(95% CI)
Heterogeneity (I2)
Breast cancer Visual impairment N = 3 studies [5,20,33] 0.63 (0.51–0.77) 95%
Breast cancer Psychosocial N = 7 studies [22,23,24,25,26,31,32] 0.69 (0.60–0.80) 100%
Cervical cancer Psychosocial N = 6 studies [22,24,27,28,29,32] 0.64 (0.34–1.18) 100%